EP 1407042 A2 20040414 - MEANS AND METHODS FOR MONITORING PROTEASE INHIBITOR ANTIRETROVIRAL THERAPY AND GUIDING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV/AIDS
Title (en)
MEANS AND METHODS FOR MONITORING PROTEASE INHIBITOR ANTIRETROVIRAL THERAPY AND GUIDING THERAPEUTIC DECISIONS IN THE TREATMENT OF HIV/AIDS
Title (de)
MITTEL UND VERFAHREN ZUR ÜBERWACHUNG EINER ANTIRETROVIRALEN PROTEASEINHIBITORTHERAPIE UND ALS RICHTSCHNUR FÜR THERAPEUTISCHE ENTSCHEIDUNGEN BEI DER BEHANDLUNG VON HIV/AIDS
Title (fr)
DISPOSITIF ET METHODES DE SURVEILLANCE D'UNE THERAPIE ANTIRETROVIRALE INHIBITRICE DE LA PROTEASE ET DETERMINATION DE DECISIONS THERAPEUTIQUES DANS LE TRAITEMENT DU VIH/SIDA
Publication
Application
Priority
- US 0218684 W 20020604
- US 87447201 A 20010604
- US 0201682 W 20020118
Abstract (en)
[origin: WO02099387A2] This invention relates to antiviral drug susceptibility and resistance tests to be used in identifying effective drug regimens for the treatment of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS), particularly treatment regimens including a protease inhibitor. The invention further relates to the means and methods of monitoring the clinical progression of HIV infection and its response to antiretroviral therapy using phenotypic or genotypic susceptibility assays.
IPC 1-7
IPC 8 full level
C07K 14/16 (2006.01); C12Q 1/37 (2006.01); C12Q 1/70 (2006.01); G01N 33/569 (2006.01)
CPC (source: EP)
C07K 14/005 (2013.01); C12Q 1/37 (2013.01); C12Q 1/703 (2013.01); C12N 2740/16043 (2013.01); C12N 2740/16222 (2013.01); G01N 2500/10 (2013.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02099387 A2 20021212; WO 02099387 A3 20030424; EP 1407042 A2 20040414; EP 1407042 A4 20060222
DOCDB simple family (application)
US 0218684 W 20020604; EP 02744311 A 20020604